ATR-001

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameATR-001
Drug Alias NameATR-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAtriva Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtriva Therapeutics Gmbh
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A